英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Dihydro Dutasteride |
度他雄胺雜質(zhì)K |
164656-22-8 |
詳細(xì)
|
5β-Dutasteride |
度他雄胺雜質(zhì)2 |
957229-52-6 |
詳細(xì)
|
Febuxostat Impurity 2 |
非布司他雜質(zhì)2 |
1330632-46-6 |
詳細(xì)
|
Febuxostat Impurity 8 |
非布司他/非布索坦雜質(zhì)8 |
144060-62-8 |
詳細(xì)
|
Lenvatinib Impurity 7 |
樂伐替尼雜質(zhì)7 |
417714-14-8 |
詳細(xì)
|
Deacetylcefotaxime lactone |
去乙酰頭孢噻肟?jī)?nèi)酯 |
66340-33-8 |
詳細(xì)
|
Salmeterol EP Impurity F |
沙美特羅EP雜質(zhì)F |
1391054-40-2 |
詳細(xì)
|
Aprepitant Impurity 10 |
阿瑞吡坦雜質(zhì)10 |
327623-37-0 |
詳細(xì)
|
Acotiamide Impurity 9 Hydrochloride |
阿考替胺雜質(zhì)9 鹽酸鹽 |
206882-15-7 |
詳細(xì)
|
Etoricoxib Impurity 14 |
依托考昔雜質(zhì)14 |
646459-39-4 |
詳細(xì)
|
Lenvatinib Impurity 4 |
樂伐替尼雜質(zhì)4 |
417717-04-5 |
詳細(xì)
|
Gefitinib Impurity 6 |
吉非替尼雜質(zhì)6 |
153437-78-6 |
詳細(xì)
|
Mirabegron Impurity 5 Monomer |
米拉貝隆雜質(zhì) |
1796931-48-0 |
詳細(xì)
|
Rabeprazole Impurity 5 |
4-(3-甲氧基丙氧基)-2,3-二甲基吡啶氮氧化物 |
117977-18-1 |
詳細(xì)
|
Pramipexole Impurity 5(Pramipexole EP Impurity E) |
鹽酸普拉克索雜質(zhì)5(鹽酸普拉克索EP雜質(zhì)E) |
106006-84-2 |
詳細(xì)
|
Emtricitabine Impurity 2 |
恩曲他濱雜質(zhì)2 |
152128-77-3 |
詳細(xì)
|
Sitagliptin EP Impurity B |
西他列汀EP雜質(zhì)B |
486460-31-5 |
詳細(xì)
|
Dabigatran Impurity 23 |
達(dá)比加群酯雜質(zhì)23 |
1580491-16-2 |
詳細(xì)
|
Vildagliptin Impurity 22 |
維達(dá)列汀雜質(zhì)22 |
1032564-18-3 |
詳細(xì)
|
Aprepitant Impurity 6(R,S,S-Isomer) |
阿瑞吡坦雜質(zhì)6(R,S,S異構(gòu)體) |
172822-28-5 |
詳細(xì)
|
Erlotinib Impurity 17 |
厄洛替尼雜質(zhì)17 |
938185-06-9 |
詳細(xì)
|
Ticagrelor Impurity 105 |
替格瑞洛雜質(zhì)105 |
220353-83-3 |
詳細(xì)
|
Esomeprazole Impurity 15 |
EP雜質(zhì)H/奧美拉唑亞砜-4-氯吡啶 |
863029-89-4 |
詳細(xì)
|
PAZUFLOXACIN MESYLATE |
甲磺酸帕珠沙 |
136905-87-8 |
詳細(xì)
|
Bicalutamide EP Impurity C |
比卡魯胺EP雜質(zhì)C |
906008-94-4 |
詳細(xì)
|
Lansoprazole Impurity 7 |
蘭索拉唑雜質(zhì)7 |
1083100-27-9 |
詳細(xì)
|
Entecavir Impurity 2 |
恩替卡韋雜質(zhì)2 |
1367369-79-6 |
詳細(xì)
|
Cinacalcet Impurity 3 |
西那卡塞雜質(zhì)3 |
955373-56-5 |
詳細(xì)
|
Dabigatran Impurity 25 |
達(dá)比加群酯雜質(zhì)25 |
1643377-48-3 |
詳細(xì)
|
Brivaracetam Impurity 3 |
布瓦西坦雜質(zhì)3 |
357336-99-3 |
詳細(xì)
|
Adefovir Impurity 8 |
阿德福韋雜質(zhì)8 |
20245-85-6 |
詳細(xì)
|
Nifuratel Impurity 2 |
硝呋太爾雜質(zhì)2 |
736-53-8 |
詳細(xì)
|
Fasudil Impurity 3 |
法舒地爾雜質(zhì)3 |
1337967-93-7 |
詳細(xì)
|
Salmeterol Impurity 5(Salmeterol EP Impurity D ) |
沙美特羅雜質(zhì)5(沙美特羅EP雜質(zhì)D) |
1391052-04-2 |
詳細(xì)
|
Darifenacin Impurity 2 |
達(dá)非那新雜質(zhì)2 |
943034-52-4 |
詳細(xì)
|
Tofacitinib Impurity 11 |
托法替尼雜質(zhì)11 |
1675248-19-7 |
詳細(xì)
|
Bortezomib Impurity 5 |
硼替佐米雜質(zhì)5 |
886979-81-3 |
詳細(xì)
|
Brivaracetam Impurity 2 |
布瓦西坦雜質(zhì)2 |
357336-19-7 |
詳細(xì)
|
Cinacalcet Impurity 22 |
西那卡塞雜質(zhì)22 |
1020414-33-8 |
詳細(xì)
|
Febuxostat Impurity 15 |
非布司他/非布索坦雜質(zhì)15 |
1271738-74-9 |
詳細(xì)
|
Lenvatinib Impurity 5 |
樂伐替尼雜質(zhì)5 |
417717-20-5 |
詳細(xì)
|
Mirabegron Impurity 11 Trifluoroacetate |
米拉貝隆雜質(zhì)11 |
1684452-85-4 |
詳細(xì)
|
Sitagliptin Impurity 9 |
西他列汀雜質(zhì)9 |
1234321-81-3 |
詳細(xì)
|
Adefovir Impurity 22 |
阿德福韋雜質(zhì)22 |
142341-04-6 |
詳細(xì)
|
Salmeterol EP Impurity G |
沙美特羅EP雜質(zhì)G |
1391051-88-9 |
詳細(xì)
|
Fasudil Impurity 2 HCl |
法舒地爾雜質(zhì)2HCl |
186544-56-9 |
詳細(xì)
|
Caspofungin Impurity 38 |
卡泊芬凈雜質(zhì)38 |
1202167-57-4 |
詳細(xì)
|
Dabigatran Impurity 14 |
達(dá)比加群酯雜質(zhì)14 |
1422435-41-3 |
詳細(xì)
|
Brivaracetam Impurity 1 |
布瓦西坦雜質(zhì)1 |
357337-00-9 |
詳細(xì)
|
Dabigatran Impurity 4 |
達(dá)比加群酯雜質(zhì)4 |
1408238-40-3 |
詳細(xì)
|
Benidipine Hydrochloride |
鹽酸貝尼地平 |
91599-74-5 |
詳細(xì)
|
Axitinib Impurity 2 |
阿西替尼雜質(zhì)2 |
1348536-59-3 |
詳細(xì)
|
Entecavir EP Impurity B |
恩替卡韋EP雜質(zhì)B |
1367369-77-4 |
詳細(xì)
|
Lurasidone Impurity 84 |
魯拉西酮雜質(zhì)84 |
15753-50-1 |
詳細(xì)
|
Aprepitant Impurity 2 |
阿瑞吡坦雜質(zhì)2 |
1185502-97-9 |
詳細(xì)
|
Benidipine Impurity 3 |
貝尼地平雜質(zhì)3 |
119065-61-1 |
詳細(xì)
|
Indapamide Impurity 2(Indapamide EP Impurity B) |
吲達(dá)帕胺雜質(zhì)2(吲達(dá)帕胺EP雜質(zhì)B) |
63968-75-2 |
詳細(xì)
|
Indapamide Impurity 1(Indapamide EP Impurity A) |
吲達(dá)帕胺雜質(zhì)1(吲達(dá)帕胺EP雜質(zhì)A) |
85440-79-5 |
詳細(xì)
|
Cetirizine Impurity 6 |
西替利嗪雜質(zhì)6 |
948-54-9 |
詳細(xì)
|
Nifedipine Impurity 2 |
硝苯地平雜質(zhì)2 |
50428-14-3 |
詳細(xì)
|
Bicalutamide Impurity 2 |
比卡魯胺雜質(zhì)2 |
113299-40-4 |
詳細(xì)
|
Cinacalcet USP RC B |
西那卡塞USP雜質(zhì)B |
1271930-15-4 |
詳細(xì)
|
Enalapril Impurity 2 Maleate(Enalapril EP Impurity A Maleate) |
依那普利雜質(zhì)2(依那普利EP雜質(zhì)A馬來酸鹽) |
1356932-13-2 |
詳細(xì)
|
Moxifloxacin Impurity 4 |
莫西沙星雜質(zhì)4 |
452092-31-8 |
詳細(xì)
|
Salmeterol Impurity 3(Salmeterol EP Impurity B ) |
沙美特羅EP雜質(zhì)B |
94749-02-7 |
詳細(xì)
|
Emtricitabine Impurity 3 |
恩曲他濱雜質(zhì)3 |
1238210-10-0 |
詳細(xì)
|
Etoricoxib Impurity 13 |
依托考昔雜質(zhì)13 |
349536-39-6 |
詳細(xì)
|
Gefitinib related substance B |
吉非替尼相關(guān)物質(zhì)B |
1603814-04-5 |
詳細(xì)
|
Brivaracetam Impurity 4 (Mixture of RR SS RS and SR Isomers) |
布瓦西坦雜質(zhì)4( RR SS RS and SR異構(gòu)體混合物) |
357335-87-6 |
詳細(xì)
|
Propranolol Impurity 5 |
普萘洛爾雜質(zhì)5 |
77252-87-0 |
詳細(xì)
|
Aprepitant Impurity 7(S,S,S-Isomer) |
阿瑞吡坦雜質(zhì)7(S,S,S異構(gòu)體) |
1242175-40-1 |
詳細(xì)
|
Esomeprazole Impurity 28 |
4-氯奧美拉唑硫醚、雜質(zhì) |
220757-74-4 |
詳細(xì)
|
Emtricitabine Impurity 1 |
恩曲他濱雜質(zhì)1 |
145986-11-4 |
詳細(xì)
|
Quetiapine Impurity 2 (Quetiapine EP Impurity I) |
喹硫平雜質(zhì)2 (喹硫平EP雜質(zhì)I) |
329216-67-3 |
詳細(xì)
|
Edaravone Impurity 13 |
依達(dá)拉奉雜質(zhì)13 |
124009-63-8 |
詳細(xì)
|
Bortezomib Impurity 4 |
硼替佐米雜質(zhì)4 |
886979-78-8 |
詳細(xì)
|
Fasudil Impurity 1 |
法舒地爾雜質(zhì)1 |
1350827-92-7 |
詳細(xì)
|
Lenvatinib Impurity 6 |
樂伐替尼雜質(zhì)6 |
417717-21-6 |
詳細(xì)
|
Rabeprazole EP Impurity G |
雷貝拉唑EP雜質(zhì)G |
102804-82-0 |
詳細(xì)
|
Vildagliptin Impurity 19 |
維達(dá)列汀雜質(zhì)19 |
565452-98-4 |
詳細(xì)
|
Moxifloxacin Impurity 1 |
莫西沙星雜質(zhì)1 |
94242-51-0 |
詳細(xì)
|
Levetiracetam EP Impurity D |
左乙拉西坦EP雜質(zhì)D |
103765-01-1 |
詳細(xì)
|
Des(trifluoroethyl) Lansoprazole Sulfide |
蘭索拉唑硫化物雜質(zhì);4-羥基蘭索拉唑硫醚 |
131926-97-1 |
詳細(xì)
|
Clindamycin Impurity 4 |
克林霉素雜質(zhì)4 |
909032-77-5 |
詳細(xì)
|
Ticagrelor Impurity 5 |
替格瑞洛雜質(zhì)5 |
1788033-05-5 |
詳細(xì)
|
Erlotinib Impurity 1 |
厄洛替尼雜質(zhì)1 |
183321-82-6 |
詳細(xì)
|
Linagliptin Impurity 15 |
利格列汀雜質(zhì)15 |
666816-91-7 |
詳細(xì)
|
Entecavir Impurity 4 |
恩替卡韋雜質(zhì)4 |
1333204-94-6 |
詳細(xì)
|
Aprepitant Impurity 4(S,R,R-Isomer) |
阿瑞吡坦雜質(zhì)4(S,R,R異構(gòu)體) |
1242175-34-3 |
詳細(xì)
|
Terbinafine Impurity 4 Hydrochloride(Terbinafine EP Impurity C Hydrochloride) |
特比萘芬EP雜質(zhì)C |
187540-01-8 |
詳細(xì)
|
Simvastatin EP Impurity A Sodium Salt |
辛伐他汀EP雜質(zhì)A鈉鹽 |
101314-97-0 |
詳細(xì)
|
Benidipine Impurity 2 |
貝尼地平雜質(zhì)2 |
129262-08-4 |
詳細(xì)
|
Benidipine Impurity 1 |
貝尼地平雜質(zhì)1 |
119009-45-9 |
詳細(xì)
|
Amoxicillin EP Impurity G |
阿莫西林EP雜質(zhì)G |
188112-75-6 |
詳細(xì)
|
1-Chloro Dihydro Dutasteride |
度他雄胺EP雜質(zhì)F |
1365545-42-1 |
詳細(xì)
|
Dabigatran Impurity 28 |
達(dá)比加群酯雜質(zhì)28 |
255706-13-9 |
詳細(xì)
|
Salmeterol Impurity 4(Salmeterol EP Impurity C ) |
沙美特羅EP雜質(zhì)C |
94749-11-8 |
詳細(xì)
|
Aprepitant Impurity 5(S,R,S-Isomer) |
阿瑞吡坦雜質(zhì)(S,R,S異構(gòu)體) |
170902-81-5 |
詳細(xì)
|
Erlotinib Impurity 22 |
厄洛替尼雜質(zhì)22 |
183322-38-5 |
詳細(xì)
|
Vildagliptin Impurity 13 |
維達(dá)列汀雜質(zhì)13 |
2577-48-2 |
詳細(xì)
|